What does thalassemia really cost children and families?
NCT ID NCT07796022
First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time
Summary
This study measures the clinical, economic, and psychosocial burden of thalassemia in children and adolescents in Sohag, Egypt. Researchers will track hospital visits, blood transfusions, and complications, and estimate direct medical costs plus indirect costs like missed school and caregiver strain. They will also use questionnaires to assess quality of life, family functioning, and psychological distress. The goal is to paint a complete picture of how thalassemia affects patients and their families.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- This study could reveal the full impact of thalassemia on children and families, guiding better support services and healthcare policies.
- What could go wrong
- As an observational study, it cannot test treatments. Findings may not apply beyond the single region, and measuring burden relies on self-reports and local cost data.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study will include children and adolescents diagnosed with thalassemia who are attending pediatric hematology clinics of Sohag University Hospitals for regular follow-up, blood transfusion, or chelation therapy.
- Ages
-
2 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Children and adolescents diagnosed with thalassemia. Age from 2 to 18 years. Regular follow-up at the selected pediatric hematology clinic or thalassemia unit Exclusion Criteria:Children with other chronic hematological disorders unrelated to thalassemia. Children with severe acute illness at the time of data collection. Children or caregivers who refuse participation. \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Thalassemia particularly transfusion dependent thalassemia are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.